 
|
 |
   
- Rossor, M. Primary Degenerative Dementia. In Neurology in Clinical Practice, 3rd edition, Vol II, ed. W.G. Bradley et al., 1703-1720. 2000. Boston: Butterworth-Heinemann.
- Galasko, D. et al., High Cerebrospinal Fluid Tau and Low Amyloid ß42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype. Archives of Neurology 1998;55:937-945.
- Andreasen, N. et al., Cerebrospinal Fluid ß-Amyloid(1-42) in Alzheimer Disease. Archives of Neurology 1999; 56:673-680.
- Selkoe, D. The Origins of Alzheimer's Disease. JAMA 2000; 283:1615-1617.
- Naslund, J. et al., Correlation Between Elevated Levels of Amyloid ß-Peptide in the Brain and Cognitive Decline. JAMA 2000; 283:1571-1577.
- Crutcher, K.A. et al., A New Hypothesis for the Role of Apolipoprotein E in Alzheimer's Disease Pathology. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, ed. K. Iqbal et al., 543-551. 1997. Chichester: John Wiley & Sons.
- Saido, T.C. et al., Post-secretory Catabolism of ß-Amyloid in Brain. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, ed. K. Iqbal et al., 338-346. 1997. Chichester: John Wiley & Sons.
- Andreasen, N. et al., A Community-based Follow-up Study on Cerebrospinal Fluid Tau Protein in Patients with Dementia. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, ed. K. Iqbal et al., 149-154. 1997. Chichester: John Wiley & Sons.
- Frey, P. et al., Search for Inhibitors of Tau Hyperphosphorylation. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, ed. K. Iqbal et al., 447-453. 1997. Chichester: John Wiley & Sons.
- Galasko, D. Cerebrospinal Fluid Opens a Window on Alzheimer's Disease. Archives of Neurology 1999. 56:655-656.
- Consensus Report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease." The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group. Neurobiology of Aging 1998; 19(2):109-116.
|
